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Abstract
Excitation/inhibition imbalance has been proposed as a fundamental mechanism in the pathogenesis of
neuropsychiatric and neurodevelopmental disorders, in which copy number variations of the Unc-51 like kinase 4
(ULK4) gene encoding a putative Serine/Threonine kinase have been reported in approximately 1/1000 of patients
suffering pleiotropic clinical conditions of schizophrenia, depression, autistic spectrum disorder (ASD), developmental
delay, language delay, intellectual disability, or behavioral disorder. The current study characterized behavior of
heterozygous Ulk4+/tm1a mice, demonstrating that Ulk4+/tm1a mice displayed no schizophrenia-like behavior in acoustic
startle reactivity and prepulse inhibition tests or depressive-like behavior in the Porsolt swim or tail suspension tests.
However, Ulk4+/tm1a mice exhibited an anxiety-like behavioral phenotype in several tests. Previously identiﬁed hypo-
anxious (Atp1a2, Ptn, and Mdk) and hyper-anxious (Gria1, Syngap1, and Npy2r) genes were found to be dysregulated
accordingly in Ulk4 mutants. Ulk4 was found to be expressed in GABAergic neurons and the Gad67+ interneurons
were signiﬁcantly reduced in the hippocampus and basolateral amygdala of Ulk4+/tm1a mice. Transcriptome analyses
revealed a marked reduction of GABAergic neuronal subtypes, including Pvalb, Sst, Cck, Npy, and Nos3, as well as
signiﬁcant upregulation of GABA receptors, including Gabra1, Gabra3, Gabra4, Gabra5, and Gabrb3. This is the ﬁrst
evidence that Ulk4 plays a major role in regulating GABAergic signaling and anxiety-like behavior, which may have
implications for the development of novel anxiolytic treatments.
Introduction
Anxiety disorders are a category of mental disorders,
including generalized anxiety disorder, panic disorder and
phobias, characterized by feelings of anxiety and fear.
They are the most common mental illness with an esti-
mated prevalence of approximately 20% of world popu-
lation, affecting 69 million of people in the EU1. Recently
a meta-analysis was carried out and showed that deletions
of 33 hypo-anxious genes were accompanied with
increased anxiety, whereas deletions of other 34 hyper-
anxious genes were shown to result in decreased anxiety,
with both presynaptic and postsynaptic genes involved2.
Clinical evidence suggests that altered GABA trans-
mission contributes to the pathophysiology of anxiety
disorders in humans. The inhibitory neurotransmitter
GABA is synthesized from glutamate by two distinct
enzymes, Gad67 (encoded by Gad1) and Gad65 (encoded
by Gad2)3,4. The levels of circulating GABA in the central
nervous system is largely determined by the Gad67+ cells,
as deletion of the Gad1 gene results in >90% reduction in
basal GABA levels, whereas Gad2−/− mice expressed
normal levels of GABA5,6.
Previous studies from our group have shown that Unc-
51 like kinase 4 (ULK4), a gene encoding a putative Ser/
Thr kinase, is co-expressed in Gad67+ neurons in the
cortex and hippocampus of mouse and human brains7. In
a follow-up study, we showed that ULK4 was deleted in
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1.2/1000 of patients with developmental delay, language
delay, severe intellectual disability, and behavior disorder8.
Recent studies from our group and others have demon-
strated that Ulk4 is involved in cortical development8–10,
ciliogenesis, and CSF ﬂow11 in the brain.
In this study, we performed a series of behavioral tests
in the Ulk4+/tm1a mice, as patients carry one copy of
ULK4 gene deletion, and the majority of the Ulk4tm1a/tm1a
mutant mice die within the ﬁrst 3 postnatal weeks11. We
demonstrated that the Ulk4+/tm1a mice exhibited anxiety-
related phenotype, with no signiﬁcant alteration in
schizophrenia-related behavior such as prepulse inhibi-
tion (PPI), acoustic startle reactivity (ASR), or depression-
like behavior of Porsolt swim test (PST) and tail suspen-
sion test (TST). This anxiety-related phenotype was
accompanied by an imbalanced expression of hypo-
anxious and hyper-anxious genes, reduced expression of
markers for GABAergic interneuron subtypes, decreased
Gad67+ cells in the hippocampus and basolateral amyg-
dala and increased GABA receptors.
Materials and methods
Ulk4 hypomorph mice
The Ulk4+/tm1a mice were created from ES cell clone
EPD0182_4_E12 on C57BL/6N background12. The gene
targeting was done by inserting a FRT-En2SA-IRES-LacZ-
PA-hBactP-Neo-PA-FRT-loxP cassette into the intron 6 of
the Ulk4 gene. The construct was designed to truncate the
Ulk4 transcription after exon 6 by fusing with En2SA-
IRES-LacZ-PA containing an En2 splicing acceptance
(En2SA) site. We previously shown that low levels of Ulk4
mRNA expression were detected in homozygous
Ulk4tm1a/tm1a mutants using primers downstream of the
exon 6, and this could be resulted from the leaking of the
construct and/or alternative splicing, despite the Ulk4
isoforms are largely unknown. The Ulk4tm1a/tm1a strain is
therefore regarded as a hypomorph model, rather than a
null mutant11. The genotyping was carried out by poly-
merase chain reaction (PCR). The wild-type (WT) allele
was detected by a 271 bp PCR product using primers
Ulk4EndE7For (5′-TAACTTGCTGGACGGATTGCT
G-3′) and Ulk4EndIn7Rev (5′-TGATCTGTAATCG-
CAGTGCAGG-3′). The mutant allele gave rise to a
621 bp DNA band using primers Ulk4KOMPKOFor
(5′-GAGATGGCGCAACGCAATTAATG-3′) and Ulk4-
KOMPKORev (5′-CTGAGGAGACAATGTAACCAGC-
3′)8,11.
All experimental procedures were approved by the
Irish Department of Health and Children in accordance
with Cruelty to Animals Act of 1876 and by the Institu-
tional Animal Care and Research Ethics Committee.
The Ulk4+/tm1a and WT littermates were generated
from Ulk4+/+×Ulk4+/tm1a mating for behavioral tests
and immunohistochemistry. Mice were group-housed
according to gender after weaning, and kept at 21± 2 °C
under 12:12 h light dark (lights on from 07.00 to 19.00 h).
All behavioral experiments were carried out between
10.00 and 17.00 h from 8 week old. For RNA sequencing,
the Ulk4tm1a/tm1a mice and WT littermates were pro-
duced by Ulk4+/tm1a×Ulk4+/tm1a mating.
Three-chamber sociability and social novelty preference test
The sociability and social novelty preference test were
carried out in a three-chamber apparatus13–16. Each ani-
mal was placed into the center of the arena and allowed
access to all chambers for 10min. Distance moved and
time spent in each compartment was assessed to evaluate
general locomotor activity and preference for any com-
partment. Following this acclimatization period, two
identical small cages were placed in the two-side cham-
bers, one containing an unfamiliar stimulus mouse of the
same sex, which was randomly assigned to either the right
or left chamber of the arena (sociability testing). The test
animal was then allowed to freely explore the entire arena
for a further 10min and behavior recorded. Following
this, the test animal was conﬁned to the central chamber,
while a second unfamiliar mouse of the same sex to the
test mouse was placed into the empty wire cage (social
novelty preference). The test animal was then allowed to
freely explore the arena for further 10 min and behavior
recorded. Distance moved in the arena, time spent in each
chamber, as well as duration and frequency of engaging in
investigatory behavior were assessed. All behaviors were
evaluated with the aid of EthoVision XT software (Noldus
Netherlands).
Novel open ﬁeld test
Mice were placed in a novel open ﬁeld arena (30× 30×
30 cm) for a 20-min period and behavior was recorded
onto a DVD. Distance moved and time spent on grooming
were assessed using Ethovision XT software (Noldus
Netherlands).
Marble burying test (MBT)
The MBT is a well-validated screen for anxiety/neo-
phobia-related behavior. This test was carried out as
described17,18 with minor modiﬁcations. A novel test cage
contained 15-cm deep wood shavings bedding, with 15
black glass marbles arranged in an equidistant 5× 3 grid
on top of the bedding. Animals were placed in the testing
arena for 20 min, and the number of buried marbles was
recorded and statistically analyzed.
Elevated plus maze (EPM)
The EPM arena consisted of a wooden apparatus, ele-
vated to a height of 55 cm above the ﬂoor, with two open
(50× 10 cm, lux 65) and two closed arms (50× 10× 30
cm, lux 30) extending from a central platform (10× 10
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cm)19. Mice were placed individually on the central plat-
form facing an open arm and behavior in the arena
recorded over a 5-min period. Anxiety-related behavior
was analyzed by using Ethovision XT software and the
time spent in open and closed arms, and the number of
entries by the subjects into the open arms assessed.
Locomotor activity was assessed as distance moved over
the trial duration.
Histology and immunohistochemistry
The histology and immunohistochemistry were carried
out as previously described8,11 in ﬁve WT females and ﬁve
lk4+/tm1a females. The primary antibody was mouse anti-
Gad67 (MAB5406, Millipore). The secondary antibody
was biotinylated goat anti-mouse (71-00-18, KPL).
Gad67+ neurons were stained with diaminobenzidine,
and imaged under a bright ﬁled microscope (IX41,
Olympus) equipped with a camera.
Brain structures were delineated according to the
mouse brain atlas20. Images were taken at 4× objective
lens, under an Axiovert 40CFL microscope (Zeiss). Cell
counting for GAD67+ neurons was performed on the
basolateral amygdaloid complex surrounded by the
amygdala capsule (Bregma-1.34–1.70 mm). The mean cell
numbers in the outlined basolateral amygdala and hip-
pocampus from 6–10 coronal serial sections/mouse were
used for statistical analysis. The X-gal staining was carried
out to reveal the Ulk4 expression pattern as the Ulk4+/
tm1a strain was an insertional mutation. The staining
solution contained 1mg/ml X-gal, 5 mm K4Fe(CN)6, 5
mm K3Fe(CN)6, 2 mm MgCl2, 0.02% Nonidet P-40,
0.01% sodium deoxycholate in PBS11.
RNA transcriptome analyses and target validation
RNA was extracted from P12 cortex of one male and
two female WT mice and three female Ulk4tm1a/tm1a
mutants. Whole-genome RNA sequencing and analyses
were performed by BGI and transcriptome was analyzed
on the top 1945 differentiated expressed genes as pre-
viously described11. Quantitative RT-PCR was carried out
to validate gene expression of selected Ulk4 targets.
Single-strand cDNA was reversely transcribed from cor-
tical RNA of four WT and four Ulk4tm1a/tm1a mice. Triple
qRT-PCR reactions were performed for each primer pair,
included PvalbFor 5′-TGTCGATGACAGACGTGCTC-3′
and PvalbRev 5′-ACCTTCTTCACCTCATCCGG-3′ (138
bp); MdkFor 5′-TGAAGAAGGCGCGGTACAATG-3′
and MdkRev 5′-ATATCTTGGGCCTGTGGGAGA-3′
(186 bp); Gng2For 5′-GATAAGCTGTCGCCCCATGT-3′
and Gng2Rev 5′-GGGTTCATTCCTGCTTGGAG-3′
(158 bp); Slc38a1For 5′-GCCATGTCTTGGTGACCAT
C-3′ and Slc38a1Rev 5′-ATCTCCGTCCTGGTTCGT
GA-3′ (167 bp); Slc38a2For 5′-TTACGGACACGTGGA
ATCGG-3′ and Slc38a2Rev 5′-
AGTGACGGAACTCCGGATAG-3′ (148 bp); Slc38a3For
5′-TGTTCTGTTCCCG
GTACGAC-3′ and Llc38a3Rev 5′-GTTGGGGGCGAA-
GATAACCA -3′ (133 bp). Each plate was loaded with
house-keeping reaction mixtures and corrected for
GapdhFor 5′-CTCATGACCACAGTCCATGC-3′ and
GapdhRev 5′-CACATTGGGGGTAGGAACAC-3′ as
cDNA loading. Relative RNA abundance in the Ulk4tm1a/
tm1a cortex was calculated using 2ΔΔCt, with average
expression level of the corresponding gene in the
WT littermates as 100%. The data were presented as
mean± standard error of the mean (SEM), n= 4 each,
*p< 0.05.
Statistical analysis
All data were expressed as mean± SEM. Behavioral data
were analyzed with two-way ANOVA when both sex and
genotype were considered or one-way ANOVA when only
one factor was considered. The immunohistochemistry
data were analyzed using one-way ANOVA. Data were
considered signiﬁcant when p< 0.05. For RNA sequen-
cing, expression data were normalized to FPKM (frag-
ments per kilobase of transcript per million mapped
reads). The differentially expressed genes were shortlisted
with p-values of multiple testing and false discovery rates
(FDRs), and transcriptome pathways were carried out as
previously analyzed11.
Results
Ulk4+/tm1a male mice exhibit impaired social novelty
preference
Ulk4+/tm1a mice were comprehensively examined
for behavioral changes, as single-copy deletion of
the ULK4 gene was identiﬁed in patients of neu-
ropsychiatric and neurodevelopmental disorders7,8. We
tested schizophrenia-related positive or negative symp-
toms by ASR, PPI, and depression-related behavior using
the PST and TST. Ulk4+/tm1a mice exhibited no sig-
niﬁcant difference from the WT littermates in any of
these tests (Supplementary Figs. S1, S2, S3).
We next investigated the sociability and preference for
social novelty in three-chamber apparatus (Fig. 1a), as
impaired social behavior is common in neurodevelop-
mental and neuropsychiatric disorders. During the 10-
min habitation period, Ulk4+/tm1a mice displayed no zone
preference (Fig. 1b). In the subsequent 10-min sociability
test, all animals spent signiﬁcantly (p< 0.01) more time in
the chamber with a novel con-speciﬁc mouse (of the same
sex as the test mouse) than in the center zone or the
chamber with an empty cage, with no statistical difference
between WT and Ulk4+/tm1a mice (Fig. 1c). In the social
novelty preference test (Fig. 1d), all mice spent sig-
niﬁcantly increased time in the chamber with a novel
mouse than the chamber containing the familiar mouse
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(p< 0.01). However, Ulk4+/tm1a male spent signiﬁcantly
less time interacting with the novel male mouse in com-
parison to WT male (Fig. 1d, p< 0.05), an effect not
observed in female counterparts. This suggests that Ulk4
mutation may inﬂuence social novelty preference of male
mice.
Ulk4+/tm1a female mice exhibit anxiety-related behavior in
the MBT
Repetitive or stereotypical behavior is common in
anxiety and ASD. As such we examined duration of
grooming behavior as a measure of repetitive activity in
open ﬁeld test. There was no genotype-speciﬁc difference
on the distance moved during the test (p= 0.23), although
males (both WT and Ulk4+/tm1a) displayed lower loco-
motor activity than corresponding females (Fig. 2a). For
grooming behavior, Ulk4+/tm1a male mice displayed more
repetition-like activity, with grooming time doubled (77.3
± 6.3 s, n= 17) when compared to Ulk4+/tm1a female
(39.8± 5.1 s, n= 13, p< 0.01, Fig. 2b), whereas WT male
mice exhibited no difference in duration of grooming
from WT female (p= 0.20). Temporal analysis of
grooming behavior over the 20 min trail demonstrated
that Ulk4+/tm1a female failed to increase grooming activity
in the last 10 min of the trial when compared to other
groups (WT female: 31.63± 4.10 s vs. Ulk4+/tm1a female:
19.86± 3.18 s; p< 0.05), and also showed lower rearing
activity than WT female (Fig. 2c), suggesting that Ulk4+/
tm1a females fail to acclimatize the novel arena possibly
due to enhanced anxiety-related behavior.
To further evaluate anxiety-like behavior, we carried out
the MBT14,15. Ulk4+/tm1a females buried signiﬁcantly
more marbles (9.6± 1.0, n= 13) than WT females (5.9±
1.0, n= 20, p= 0.01, Fig. 2d). The Ulk4+/tm1a group as a
whole also buried signiﬁcantly more marbles (7.8± 0.8,
n= 32) than the WT group (5.6± 0.7, n= 38, p= 0.03).
This further conﬁrmed anxiety-like or neophobia-like
behavior in Ulk4+/tm1a mice.
Ulk4+/tm1a mice exhibit anxiety-related behavior on the
EPM
We next carried out EPM test16 to further assess
anxiety-like behavior in the mutant mice. Female mice
exhibited greater locomotor activity on the EPM than
males in consistency with the open ﬁeld test, although this
was not genotype-speciﬁc (Fig. 3a). Both Ulk4+/tm1a male
Fig. 1 Ulk4+/tm1a male mice display reduced social novelty preference. a WT male (n = 18), WT female (n = 20), Ulk4+/tm1a male (n = 20), and
Ulk4+/tm1a female (n = 14) were tested in three-chamber apparatus. b No zone preference during the habitation period (p > 0.05). c No genotype
difference in sociability test. All animal spent more time in the arena with the novel stimulus animal vs. time in center or in arena of novel object (p <
0.01). d Social novelty tests showing that Ulk4+/tm1a male spent signiﬁcantly less time interacting with the novel animal in comparison to the WT male
(*p < 0.05)
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and female mice spent signiﬁcantly less time in the open
arms of the EPM than WT counterparts (Fig. 3c, d). Thus,
Ulk4+/tm1a mice display an elevated anxiety-like behavior
in the EPM.
Ulk4+/tm1a mice show fewer Gad67+ cells in basolateral
amygdala and hippocampus
Neuroanatomic analysis demonstrated normal brain
morphology in Ulk4+/tm1a mice, with no schizophrenia-
Fig. 2 Ulk4+/tm1a female mice displayed decreased grooming activity, reduced rearing, but increased marble burying. a–c 20 WT female, 18
WT male, 13 Ulk4+/tm1a female, and 17 Ulk4+/tm1a male at 2–3-month-old were placed in an open ﬁeld arena for 20 min. a There was no genotype-
speciﬁc but gender-associated difference in distance traveled. b The duration spent on grooming was reduced in Ulk4+/tm1a female (39.8 + 5.1, n = 13)
compared with Ulk4+/tm1a male (77.3 + 6.3, n = 17, p < 0.01). c Ulk4+/tm1a female also showed reduced rearing activity (240.2 + 14.2, n = 13, p = 0.02)
than WT Female (287.7 + 12.1, n = 20). d Ulk4+/tm1a female and total Ulk4+/tm1a mice showed signiﬁcant increase in marble burying compared to WT
female and total WT mice
Fig. 3 Both Ulk4+/tm1a male and female mice exhibit an increased anxiety on EPM test. a Distance moved; b time spent in the closed arms; c
time spent in open arms; and d percentage of time spent in the open arms. Male and female Ulk4+/tm1a mice and their WT littermates were subjected
to the EPM. Data are expressed as mean ± SEM; n = 12–19 per group. *p < 0.05
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related or hydrocephalus-related phenotype (Supple-
mentary Fig. 4). Thus, a single copy of Ulk4 gene deletion
does not affect gross neuroanatomy in mice. We pre-
viously showed that Ulk4 is expressed in GABA neurons7,
and altered GABA signaling is implicated in neuro-
pathology of the neuropsychiatric illness. The amygdala
and hippocampus are key brain regions associated with
anxiety, fear, and learning. We took advantage of lacZ
reporter gene in the Ulk4 mutant, performed X-gal
staining, and demonstrated the strongest β-gal activity
in the medial part of the basolateral amygdala (Fig. 4a)
and in the CA1 region of the hippocampus (Fig. 4h). We
subsequently carried out anti-Gad67 staining in 2-month
WT and Ulk4+/tm1a mice, and quantiﬁed Gad67+ cells
(Fig. 4b, c) from comparable sections in the basolateral
amygdaloid complex and hippocampus. The data revealed
there were 72.9± 6.3 Gad67+ cells in the WT basolateral
amygdala, with a cell density of 109.8 ± 13.3 cells/mm2
(Fig. 4b, c). In Ulk4+/tm1a mice, 50.9± 1.7 Gad67+ cells
were found in the equivalent region with a cell density of
58.7± 11.1 (Fig. 4b–e). These data demonstrated a sig-
niﬁcant reduction of Gad67+ cells (p= 0.01) and cell
density (p= 0.02) in the amygdala of the Ulk4+/tm1a mice.
In the hippocampus, an average of 146.0± 4.3 Gad67+
cells was found on the WT hippocampus, whereas Ulk4+/
tm1a mice exhibited an average cell number of 110.6± 8.2
cells (Fig. 4f, g, i, j, n= 5 each, p< 0.01). This was resulted
from general decrease of Gad67+ cells in the CA1 (81.2±
3.0 vs. 62.9± 6.1, p< 0.05), CA2 (13.7± 1.9 vs. 10.3± 0.7,
p> 0.05), CA3 (27.0± 2.8 vs. 19.0± 0.9, p< 0.05), and DG
(24.1± 1.2 vs. 18.4± 1.4, p< 0.05) of Ulk4+/tm1a vs. WT
mice. Therefore, these data demonstrated that Ulk4+/tm1a
mice exhibit reduced numbers of GABAergic neurons in
the basolateral amygdala and hippocampus, thus possibly
provide the cellular mechanism for the anxiety-like
behavior in Ulk4+/tm1a mice.
Reduced expression of markers for GABAergic interneuron
subtypes in the Ulk4tm1a/tm1a
GABAergic interneurons are the major inhibitory
neurons, with >12 distinct subtypes of GABAergic
interneurons expressing calretinin (Calb2), somatostatin
(Sst), cholecystokinin (Cck), neuropeptide Y (Npy),
vasointestinal polypeptide (Vip), choline acetyltransferase
(Chat), and NOS21. To systematically evaluate the effect
of Ulk4 lesion of the various GABA interneuron subtypes,
we carried out transcriptome analyses in the WT and
Ulk4tm1a/tm1a mice by whole-genome RNA sequencing.
The expression of Pvalb, Sst, Cck, Npy, and Nos3 were
all reduced in Ulk4 mutants (Table 1). Pvalb-expressing
cells constitute 39% of GABA interneurons and are
vital for neuronal synchronization. Notably Pvalb was
37% reduced in Ulk4 mutants (p= 4.33E-07, FDR=
9.01E-06). Together these data support a substantial
reduction of pre-synaptic GABA interneurons in Ulk4
mutants.
Disrupted GABAergic synapse in Ulk4tm1a/tm1a mice
Analyses of the top 1945 differentially regulated genes
(FDR< 0.025, p< 0.0033) identiﬁed “Synapse” pathway
(FDR= 1.51E-18) with 124 genes signiﬁcantly altered in
Ulk4 mutants. More “Postsynapse” genes (n= 72, FDR=
1.55E-12) were affected than “Presynapse” genes (n= 26,
FDR= 1.03E-03). KEGG pathway analyses showed that 16
genes in the GABAergic synapse (FDR= 0.016) were
signiﬁcantly dysregulated in Ulk4 mutants (Table 1).
Whereas Gng7, Gng4, Slc38a3, and Slc38a5 were down-
regulated in mutants, postsynaptic targets Gabra1,
Gabra3, Gabra4, Gabra5, and Gabrb3 genes were sig-
niﬁcantly upregulated, together with overexpression of
Nsf, Slc38a1, Slc38a2, Hap1, Gng2, Adcy9, and Cacna1c.
This highlights that Ulk4tm1a/tm1a mutation signiﬁcantly
alters both pre-synaptic and post-synaptic GABAergic
signaling.
Ulk4 regulates hyper-anxious and hypo-anxious gene
expression
The previous meta-analysis identiﬁed 33 hypo-anxious
and 34 hyper-anxious genes2. The quantitative RNA
sequencing showed that three hypo-anxious genes Atp1a2
(FDR= 1.40E-114), Ptn (FDR= 7.57E-17), and Mdk
(FDR= 1.75E-03) were reduced to 77, 80, and 63% in
Ulk4 mutants. Meanwhile, four hyper-anxious genes
Gria1 (123%, FDR= 2.65E-14), Syngap1 (114%, FDR=
1.06E-08), Npy2r (213%, FDR= 0.001), and Ptpra (111%,
FDR= 0.002) were signiﬁcantly increased. Therefore
deletion of the Ulk4 gene is associated with imbalanced
expression of hyper-anxious and hypo-anxious genes
(Table 1).
Validation of the Ulk4 target gene expression
Whole-genome RNA sequencing is one of the most
sensitive methods to detect transcriptome changes at the
genome level. Here, we carried out quantitative RT-PCR
on six selected Ulk4 targets, the downregulated Pvalb,
Mdk, and Slc38a3, and upregulated Slc38a1, Slc38a2, and
Gng2. The transcription of Slc38a1, Slc38a2, and Gng2
was increased to 115, 122, and 127%, respectively, in the
Ulk4 vs. WT counterparts, but was statistically not sig-
niﬁcant (Fig. 5, p> 0.05). However, the Pvalb, Mdk, and
Slc38a3 transcripts were reduced to 46.9, 58.7, and 57.8%
(Fig. 5, n= 4 each, p< 0.05), respectively, in the Ulk4
mutants vs. WT controls. Of particular relevance is the
signiﬁcant reduction of Pvalb transcripts for parvalbumin,
which marks a major subgroup of GABA inhibitory
interneurons. Parvalbumin deﬁciency is a landmark neu-
ropathology of schizophrenia22 and is associated with
mouse model of ASD23.
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Discussion
Previously, we showed that ULK4 was expressed in
GABA neurons and ULK4 CNVs were found in neuro-
developmental and neuropsychiatric disorders7,8. In this
study, we report the ﬁrst evidence that Ulk4 regulates
GABAergic signaling in the brain, and Ulk4 heterozygous
mice display anxiety-related phenotype, a prominent
component of many neuropsychiatric diseases.
The ULK4 CNVs occur at a rate of 0.14% (16/11,633)
from two previous studies7,8, lower than NRXN1 CNVs
as a major target for schizophrenia (0.18–0.63%)24–26,
and ASD (0.45%)27,28. The ULK4 mutation rate may rise
when the whole-exome or genome are sequenced. How-
ever, the clinical features of ULK4 CNVs are pleiotropic,
which include schizophrenia, ASD, bipolar disorder7,
developmental delay, severe language delay, learning
difﬁculties, and behavioral disorder8. Therefore,
comprehensive behavioral tests were performed on the
Ulk4+/tm1a mice in this study. Ulk4+/tm1a mice exhibit
no obvious schizophrenia-related or depression-related
phenotype, as they did not show statistic difference from
WT littermates in ASR, PPI, PST, or TST.
However, Ulk4+/tm1a mice display anxiety-related
behavior in a number of behavioral paradigms. Both
Ulk4+/tm1a male and female mice spent signiﬁcantly less
time on the open arms but more time in the closed arms
in the EPM test, a well-recognized measure of anxiety-
related behavior. Ulk4+/tm1a male mice interacted less
with the novel vs. familiar animal, indicative of a deﬁcit in
social novelty preference possibly due to social neo-
Fig. 4 Reduced Gad67+ cells in the amygdala and hippocampus of Ulk4+/tm1a mice. X-gal staining showed Ulk4 expression in the basolateral
amygdala (a) and hippocampus (b). Anti-Gad67 immunohistochemistry was carried out on brain section of ﬁve female WT and ﬁve Ulk4+/tm1a female
mice at 2 months. The Gad67+ cells were quantiﬁed from the equivalent regions as outlined in WT (0.68 ± 0.05 mm2, n = 5) and Ulk4+/tm1a (0.64 ± 0.04
mm2, n = 5) mice. The Gad67+ cells were quantiﬁed from comparable sections of the CA1 (81.2 ± 3.0 in WT vs. 62.9 ± 6.1 in Ulk4+/tm1a, p = 0.03), CA2
(13.7 ± 1.9 in WT vs. 10.3 ± 0.7 in Ulk4+/tm1a, p = 0.13), CA3 (27.0 ± 2.8 in WT vs. 19.0 ± 0.9 in Ulk4+/tm1a, p < 0.02), DG (24.1 ± 1.2 vs. 18.4 ± 1.4, p < 0.02),
WT hippocampus (146.0 ± 4.3) and Ulk4+/tm1a hippocampus (110.6 ± 8.2, p < 0.01) and statistically analyzed (g), showing signiﬁcant reduction of
Gad67 cells (e) and cell density in Ulk4+/tm1a Amygdala (f) and a signiﬁcant reduction (p < 0.05) of Gad67 cells in the hippocampus (g) of Ulk4+/tm1a
mice. Bar = 200 µm in a, b, c, h, i, j. *p < 0.05; **p < 0.01
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Table 1 Ulk4 regulates GABAergic signaling, hyper-anxious, and hypo-anxious genes
WT (FPKM) Ulk4 mutants (FPKM) Average mutant/WT Up-down (mutant/WT) p-value FDR
GABA subtypes
Pvalb (39%) 28.7 ± 2.9 18.0 ± 3.0 0.63 Down 4.33E-07 9.01E-06
Sst (23%) 382.4 ± 22.8 324.9 ± 11.9 0.85 Down 7.97E-10 2.61E-08
Cck (5%) 437.7 ± 3.8 358.0 ± 1.9 0.82 Down 2.52E-17 1.80E-15
Npy (8%) 257.1 ± 9.9 196.8 ± 21.4 0.77 Down 1.19E-14 6.84E-13
Nos3 (<1%) 4.6 ± 0.4 3.1 ± 0.6 0.67 Down 1.09E-04 1.35E-03
Calb2 (24%) 11.2 ± 0.3 16.3 ± 1.8 1.45 Up 5.29E-05 7.07E-04
Vip (11%) 18.9 ± 1.3 23.2 ± 3.4 1.23 Up 4.04E-03 3.05E-02
GABAergic synapse pathway
Gng4 47 ± 3.1 40.1 ± 4.3 0.85 Down 5.26E-05 7.04E-04
Gng7 142.6 ± 15.9 107.8 ± 33.4 0.76 Down 5.00E-53 1.82E-50
Slc38a3 42.5 ± 5.6 31.5 ± 7.4 0.74 Down 2.37E-10 8.49E-09
Slc38a5 7.1 ± 1.4 3.7 ± 1.4 0.53 Down 8.81E-06 1.43E-04
Adcy9 9.7 ± 0.8 13.4 ± 2.2 1.39 Up 1.91E-13 9.77E-12
Cacna1c 7.2 ± 0.4 8.6 ± 0.5 1.19 Up 3.57E-05 4.98E-04
Gabra1 78.4 ± 8.5 95 ± 8.7 1.21 Up 2.55E-22 2.60E-20
Gabra3 36.5 ± 2.5 44.4 ± 3 1.21 Up 1.24E-08 3.39E-07
Gabra4 32.7 ± 1.6 38.8 ± 1.5 1.19 Up 3.91E-07 8.21E-06
Gabra5 35.5 ± 0.3 43.3 ± 4.9 1.22 Up 2.03E-06 3.76E-05
Gabrb3 74.8 ± 5.8 95.5 ± 8.9 1.28 Up 6.62E-35 1.29E-32
Gng2 85.6 ± 2 103.2 ± 10.7 1.20 Up 1.35E-16 8.93E-15
Hap1 15.7 ± 2.2 26.6 ± 5 1.70 Up 4.26E-24 4.92E-22
Nsf 174.4 ± 15.1 214.9 ± 9.8 1.23 Up 3.11E-38 7.03E-36
Slc38a1 21.7 ± 0.8 28.1 ± 1 1.30 Up 5.89E-18 4.41E-16
Slc38a2 21.3 ± 0.6 33.6 ± 8.4 1.58 Up 5.01E-33 9.04E-31
Hypo-anxious genes
Atp1a2 228.0 ± 18.7 175.47 ± 19.7 0.77 Down 1.28E-117 1.40E-114
Ptn 178.6 ± 26.3 142.9 ± 33.5 0.80 Down 9.28E-19 7.57E-17
Mdk 22.8 ± 3.9 14.5 ± 6.1 0.63 Down 1.47E-04 1.75E-03
Plcb4 11.4 ± 2.4 14.9 ± 2.5 1.31 Up 1.50E-05 2.28E-04
Apoe 1085.4 ± 162.0 1127.2 ± 46.3 1.04 Up 1.56E-05 2.36E-04
Cacna1e 15.1 ± 3.5 17.0 ± 0.3 1.13 Up 2.75E-04 3.06E-03
Adra2a 8.4 ± 1.1 10.7 ± 1.7 1.28 Up 3.72E-04 3.97E-03
Hyper-anxious genes
Ncam1 96.0 ± 4.7 82.8 ± 8.5 0.86 Down 4.78E-12 2.09E-10
Gria1 48.4 ± 6.7 59.4 ± 8.3 1.23 Up 4.14E-16 2.65E-14
Syngap1 106.8 ± 10.0 121.9 ± 27.1 1.14 Up 3.03E-10 1.06E-08
Npy2r 0.9 ± 0.3 1.9 ± 0.6 2.13 Up 1.15E-04 1.41E-03
Ptpra 56.6 ± 2.2 62.9 ± 2.4 1.11 Up 1.98E-04 2.29E-03
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phobia. Ulk4+/tm1a females failed to acclimatize the
novel open ﬁeld arena at the end phase of the test, seen
as a lack of increase in grooming behavior, and buried
signiﬁcantly more marbles in the MBT. The lack of
acclimatization is likely due to the enhanced anxiety of
these animals in a novel environment and increased
marble burying is a well-recognized behavior associated
with neo-phobia/anxiety-related behavior. Thus, both
male and female Ulk4 mutants exhibit anxiety-related
behavior in several behavioral paradigms, although some
sex-related differences were noted. The reason for sex
differences in some but not all of the behavioral tests is
unknown; however, Ulk4 may regulate neuro-hormone
release and/or activity, as Ulk4 is expressed also in brain
regions mediating homeostatic control, such as the
hypothalamus and neurosecretory circumventricular
nuclei29, which may result in sex-related differences in
behavior under certain conditions. Despite the subtle
differences in responses between males and females in
individual tests, taken together, the behavioral data
demonstrate an anxiety-like phenotype in Ulk4+/tm1a
mice.
Consistent with the behavioral changes, three previously
identiﬁed hypo-anxious genes (Atp1a2, Ptn, and Mdk)
were downregulated, and four hyper-anxious genes
(Gria1, Syngap1, Npy2r, and Ptpra) were signiﬁcantly
upregulated, suggesting that Ulk4 lesion disturbs balanced
expression of hyper-anxious and hypo-anxious genes in
the brain2. Ulk4 also plays a role in neurogenesis8–10,
which is in agreement with the hypothesis that anxious
phenotype is associated with neurodevelopmental
changes2.
In addition, the G-protein-coupled signaling appears
also disrupted, as Gng4, Gng7, Adcy9, and Kcnj6 were
dysregulated in Ulk4 mutants. Gng4 and Gng7 are med-
iators of GPCR signaling linked to fear and anxiety, and
Gng4 expression was inversely correlated with fear and
anxiety in the mouse model of post-traumatic stress dis-
order30. Gng7 was signiﬁcantly downregulated in the
amygdala of Itpka KO mice which exhibited fear-related
and anxiety-related behaviors31. Subtle changes in Gng7
expression also impacted anxiety and aggressive behaviors
in transgenic animals32 and in chronic social-defeat stress
leading to depressive and anxious states33. ADCY9,
involved in cAMP production, was previously identiﬁed as
a risk factor for mood disorders34,35. However, the rele-
vance of Kcnj6 (encoding a G-protein activated inward
rectiﬁer potassium channel) dysregulation is less certain.
Kcnj6 is located on human Chr21, and trisomy Kcnj6
transgenic mice display some of the Down syndrome-like
Fig. 5 Altered gene expression identiﬁed by whole-genome RNA sequencing (a), and validated by quantitative RT-PCR (b). RNA sequencing
was carried out in three pairs of P12 WT and Ulk4tm1a/tm1a cortex, and quantitative RT-PCR in four pairs of cortical RNA (b). Whereas Slc38a1, Slc38a2,
and Gng2 genes showed increased mRNA transcripts by both methods, the Pvalb, Mdk, and Slc38a3 gene transcription were signiﬁcantly reduced (*p
< 0.05)
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neurological abnormalities, but not anxiety-related
indices36.
Overwhelming evidence suggests that abnormal GABA
transmission contributes to the pathophysiology of anxi-
ety disorders in humans37,38. For instance, studies using
nuclear imaging techniques revealed diminished central
GABA and GABA receptor levels in patients with panic
disorder, generalized anxiety disorder, and posttraumatic
stress disorder39. The GAD2 polymorphisms were shown
as a risk factor for anxiety disorders40. Genetic varia-
tions41 and reduced GAD67 expression in bipolar and
schizophrenia were also well documented42,43. Similarly,
Gad1+/− male mice also exhibit reduced Gad67+ neu-
rons, with disturbed characteristics of depression and
anxiety44. Considering signiﬁcant decreases in Gad67
neurons in the hippocampus and basolateral amygdala of
Ulk4+/tm1a mice, and the correlating functions of GAD1
in humans, it will be interesting to investigate if poly-
morphisms of the ULK4 link to anxiety disorders in
patients.
GABA transmission in the amygdala is considered
particularly important in controlling fear and anxiety. We
conﬁrmed high Ulk4 expression in the basolateral amyg-
dala and hippocampus using X-gal staining. Anti-Gad67
staining revealed signiﬁcant reduction of Gad67+ neurons
in hippocampus and amygdala of the Ulk4+/tm1a mice.
Interestingly, high β-gal activity is located in the medial
aspect of the basolateral amygdala, whereas Gad67+ cells
are more abundant in the lateral aspect of the basolateral
amygdala. In the hippocampus, strong X-gal staining is
present in the CA1, while Gad67+ cells are reduced in all
hippocampal regions. These anatomic differences in the
patterns of X-gal and Gad67 staining may be due to
alternative splicing of the Ulk4 gene, for example, Ulk4
isoforms may be started after exon 6, which will not be
revealed by X-gal staining. Alternatively, Ulk4 protein
may also be expressed in other neuronal types, other than
Gad67+ neurons, such as Gad65+ neurons or other
neuronal subtypes. We cannot rule out that the change in
Gad67+ cell number in Ulk4 mutants may also be an
indirect or compensatory consequence of Ulk4 deletion
during development and not be related to loss of Ulk4
function in GABAergic neurons. Regardless of the precise
mechanism, the data herein demonstrate that Ulk4+/tm1a
mice exhibit reduced cell number of Gad67+ neurons and
thus possibly altered GABAergic neurotransmission in the
BLA and hippocampus that may underlie the behavioral
changes observed.
In humans benzodiazepines are the most widely pre-
scribed anxiolytic drugs acting through GABA recep-
tors38. In rodents, administration of GABAAR agonists,
including muscimol, also decreases the anxiety level45,46.
GABA is synthesized from glutamate, which is trans-
ported into cells by membrane proteins. It is worth to
note that four sodium-dependent amino acid transporters
were dysregulated in the mutants. Whereas expression of
the Slc38a3 and Slc38a5 were reduced, Slc38a1 and
Slc38a2 expression were increased. These alterations were
consistent with reported anxiety phenotype. For example,
Slc38a1 was overexpressed in MeCP2 mutants, a mouse
models for RETT syndrome with communication deﬁcit,
motor impairments, hand stereotypies47, and anxiety48.
Slc38a3 is an anxiety-related response locus QTL15 in rat.
Slc38a3 and Gng4 expression were altered in EFhd2
knockout mouse associated with anxiety and alcohol
addiction49. Slc38a5 was one of the two genes dysregu-
lated in Rai1+/− mice with epilepsy, mental retardation,
and anxiety disorder50.
There are >12 subtypes of GABA interneurons in
mammalian brain21. Transcriptome analyses in this report
showed signiﬁcant reduction of many GABA interneuron
subtypes in the Ulk4 hypomorphs, including Pvalb, Sst,
Cck, Npy, and Nos3, which constituted three quarters of
total GABA interneurons in normal mice. Parvalbumin,
the most abundant subtype whose deﬁciency is a funda-
mental pathology in neurodevelopmental disorders22,23, is
signiﬁcantly downregulated in Ulk4 mutants.
Alterations in the density and number of GABAergic
neurons in the brain occur throughout postnatal devel-
opment51–53. It is not possible to identify exactly when
Ulk4 deletion would speciﬁcally alter GABAergic cell
density and/or function but rather it is likely that altera-
tions occur along the neurodevelopmental pathway.
Despite this, RNA sequencing was done on P12 Ulk4tm1a/
tm1a and WT mice which reveal alterations in expression
of GABA neuronal subtypes, and receptor subtypes.
Furthermore, in 2-month old, we show again regional
reduction of Gad67+ neurons in 2-month mice, the time
correlating with behavioral testing.
GABA interneurons play their inhibition roles largely
via brain GABAARs and GABABRs. The fast short-lasting
“phasic” inhibition is typically generated by the activation
of postsynaptic GABAARs following action potentials in
presynaptic interneurons, and the “tonic” extra-synaptic
inhibition is activated by ambient GABA in the extra-
cellular space through molecularly and functionally spe-
cialized GABAARs. Remarkably the postsynaptic
GABAergic signaling was also disrupted in Ulk4 mutants,
and this included signiﬁcant upregulation of GABAAR
subunits Gabra1, Gabra3, Gabra4, Gabra5, and Gabrb3.
Changes in these receptor subunits are consistent with the
anxiety phenotype. For example, the human GABRA5 and
GABRB3 are located in the 15q11.2-q13 region, and
maternal duplications of 15q11.2-q13 leads to neurode-
velopmental disorders including ASD, and their clinical
symptoms often include anxiety, emotional lability, tan-
trums, and hyperactivity54. Although deletion of Gabra1
in amygdala did not affect anxiety behavior55, Gabra3-
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mediated tonic inhibition in the amygdala was essential in
regulating fear and anxiety. The Gabra3-selective benzo-
diazepine site agonist and anxiolytic compound TP003
increased tonic currents and markedly dampen excit-
ability in BLA principal cells56. Gabra4 was involved in
fear extinction learning, and knockout of the extra-
synaptic GABAARs facilitated fear extinction
57. Altered
expression also included Nsf, which was shown to
downregulate GABAARs with PKCε58. We, however,
cannot rule out that Ulk4 deletion may affect GABAergic
neurotransmission in other brain regions, and Ulk4 may
be also expressed in other neurons such as glutamatergic
neurons. Examination of effects in other neurons will be
the focus of follow-up studies.
Sex bias is common in brain disorders and sex is known
to inﬂuence GABAergic transmission and anxiety-related
behavior59. The data herein demonstrate that Ulk4 dele-
tion alters various GABAergic parameters; however,
assessment of such parameters was not conducted in a
sufﬁcient number of males and females separately to
enable sex differences to be analyzed at this level. Despite
subtle sex-related differences are observed in different
behavioral paradigms, the strongest phenotype is the
increased anxiety from plus maze test, which are con-
sistent in both male and female mutants. Thus, the data
suggest that Ulk4 deletion modulates brain development
and results in GABAergic changes which may underlie the
anxiety-related phenotype.
In summary, we have shown for the ﬁrst time that Ulk4
haploinsufﬁciency in mice leads to increased anxiety-
related behavior with disturbed GABAergic signaling.
Ulk4 is involved in the maintenance of the excitation/
inhibition balance, which is commonly disturbed in neu-
rodevelopmental and neuropsychiatric disorders. There-
fore, regulation of the ULK4 activity may present an
alternative route of drug exploration for neurodevelop-
mental and neuropsychiatric illness.
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